Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashkan Shoamanesh

Showing results (1-10 of 196) with videos related to

Pageof 20
Sort By:
Lancet (London, England)|October 15, 2023
Anticoagulation in patients with cerebral amyloid angiopathyAshkan Shoamanesh,
Stroke|August 28, 2023
Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?Ashkan Shoamanesh
Neurology|September 16, 2016
Clinical relevance of microbleeds in acute stroke thrombolysis: Comprehensive meta-analysisAndreas Charidimou, Ashkan Shoamanesh,
Stroke|August 11, 2017
Identifying the Right MentorLuciana Catanese, Ashkan Shoamanesh
Stroke|June 6, 2022
Use of Lipid-Lowering Drugs After Intracerebral HemorrhageAshkan Shoamanesh, Magdy Selim
The New England Journal of Medicine|August 21, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. ReplyAshkan Shoamanesh, Mukul Sharma
Brain : a Journal of Neurology|July 19, 2022
Does the magnitude of lipid lowering with statin therapy indicate higher intracranial bleeding risk?Aristeidis H Katsanos, Ashkan Shoamanesh
Lancet (London, England)|June 10, 2024
Colchicine for the prevention of vascular events after non-cardioembolic strokeAristeidis H Katsanos, Ashkan Shoamanesh
Stroke|February 25, 2021
Combatting Secondary Injury From Intracerebral Hemorrhage With Supplemental Antioxidant TherapyAshkan Shoamanesh, Aristeidis H Katsanos
Lancet (London, England)|March 1, 2025
Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhageRustam Al-Shahi Salman, Ashkan Shoamanesh
Pageof 20

Showing results (1-10 of 196) with videos related to

Sort By:
Pageof 20
Lancet (London, England)|October 15, 2023
Anticoagulation in patients with cerebral amyloid angiopathyAshkan Shoamanesh,
Stroke|August 28, 2023
Is There Still a Role for Dual Antiplatelet Therapy in the Secondary Prevention of Lacunar Stroke?Ashkan Shoamanesh
Neurology|September 16, 2016
Clinical relevance of microbleeds in acute stroke thrombolysis: Comprehensive meta-analysisAndreas Charidimou, Ashkan Shoamanesh,
Stroke|August 11, 2017
Identifying the Right MentorLuciana Catanese, Ashkan Shoamanesh
Stroke|June 6, 2022
Use of Lipid-Lowering Drugs After Intracerebral HemorrhageAshkan Shoamanesh, Magdy Selim
The New England Journal of Medicine|August 21, 2024
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage. ReplyAshkan Shoamanesh, Mukul Sharma
Brain : a Journal of Neurology|July 19, 2022
Does the magnitude of lipid lowering with statin therapy indicate higher intracranial bleeding risk?Aristeidis H Katsanos, Ashkan Shoamanesh
Lancet (London, England)|June 10, 2024
Colchicine for the prevention of vascular events after non-cardioembolic strokeAristeidis H Katsanos, Ashkan Shoamanesh
Stroke|February 25, 2021
Combatting Secondary Injury From Intracerebral Hemorrhage With Supplemental Antioxidant TherapyAshkan Shoamanesh, Aristeidis H Katsanos
Lancet (London, England)|March 1, 2025
Towards definitive evidence about anticoagulation for atrial fibrillation after intracranial haemorrhageRustam Al-Shahi Salman, Ashkan Shoamanesh
Pageof 20